May 06, 2025 / 08:30PM GMT
Operator
Hello, everyone. And welcome to Arcus Biosciences first quarter 2025 earnings and financial results call. My name is Lydia, and I'll be your operator today. After the prepared remarks, there'll be an opportunity to ask questions (Operator Instructions) I'll now hand you over to Pia Eaves, Vice President of Investor Relations to begin. Please go ahead.
Pia Eaves - Arcus Biosciences Inc - Vice President of Investor Relations & Strategy
Good afternoon. And thank you for joining us on today's conference call to discuss Arcus' first quarter 2025 financial results and pipeline updates. I'd like to remind you that on this call management will make forward looking statements, including statements about our cash runway, our projected 2025 revenue and our expected clinical development milestones and timelines.
All statements, other than historical facts, reflect the current beliefs and expectations of management and involve risks and uncertainties that may cause our actual results to differ from those expressed. Those risks and uncertainties are described in
Q1 2025 Arcus Biosciences Inc Earnings Call Transcript
May 07, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers